Department of Periodontology, School of Dentistry, University of Aarhus, Aarhus, Denmark.
Clin Oral Implants Res. 2012 Jan;23(1):125-31. doi: 10.1111/j.1600-0501.2011.02161.x. Epub 2011 Apr 19.
The aim was to evaluate histologically the outcome of a bioglass and autogenous bone (at 1 : 1 ratio) composite implantation for transalveolar sinus augmentation.
In 31 patients, during implant installation ca. 4 months after sinus augmentation, biopsies were harvested through the transalveolar osteotomy by means of a trephine bur and non-decalcified sections through the long axis of the cylinder were produced. After a strict selection process, taking into account the presurgical residual bone height and biopsy length, 8 and 15 biopsies representing the new tissues formed inside the sinus and the transalveolar osteotomy, respectively, qualified for analysis. The tissue fractions occupied by newly formed bone (mineralized tissue+bone marrow), soft connective tissue, residual biomaterial+empty spaces, and debris inside the sinus cavity or the transalveolar osteotomy were estimated.
Bone and connective tissue fraction in the newly formed tissues inside the sinus cavity averaged 23.4 ± 13.2% and 54.1 ± 23.5%, respectively. Residual biomaterial, empty spaces, and debris averaged 1.9 ± 3.5%, 10.5 ± 6.3%, and 8.4 ± 14.5%, respectively. In the transalveolar osteotomy, bone and connective tissue fraction averaged 41.6 ± 14.3% and 46.1 ± 13%, respectively, while the amount of residual biomaterial, empty spaces, and debris was 2.8 ± 5%, 4.7 ± 1.9%, and 3.2 ± 2.6%, respectively. Statistically significant differences between the sinus cavity and the transalveolar osteotomy were found only for bone and empty spaces' values (P=0.02 and 0.04, respectively).
Sinus augmentation with a bioglass and autogenous bone composite is compatible with bone formation that, in a short distance from the floor of the sinus, shows similar density as that reported previously for other commonly used bone substitutes. New bone fraction inside the transalveolar osteotomy was almost twice as much as in the sinus cavity, while the amount of residual biomaterial was much less than that inside the sinus.
评估生物玻璃和自体骨(1:1 比例)复合材料用于牙槽窦增高术的组织学结果。
在 31 名患者中,在窦提升后约 4 个月进行种植体安装时,通过牙槽骨切开术用环钻采集活检,并通过长轴制作非脱钙切片。经过严格的选择过程,考虑到术前残留骨高度和活检长度,分别有 8 个和 15 个活检符合分析标准,代表在窦内形成的新组织和牙槽骨切开术。估计新形成的骨(矿化组织+骨髓)、软结缔组织、窦腔内或牙槽骨切开术的残留生物材料+空腔以及碎片所占的组织分数。
窦内新形成组织中的骨和结缔组织分数分别为 23.4±13.2%和 54.1±23.5%。残留生物材料、空腔和碎片分别为 1.9±3.5%、10.5±6.3%和 8.4±14.5%。在牙槽骨切开术中,骨和结缔组织分数分别为 41.6±14.3%和 46.1±13%,而残留生物材料、空腔和碎片的量分别为 2.8±5%、4.7±1.9%和 3.2±2.6%。仅在窦腔和牙槽骨切开术之间发现骨和空腔值存在统计学差异(P=0.02 和 0.04)。
生物玻璃和自体骨复合材料的窦提升与骨形成相容,在距离窦底较近的位置,其密度与先前报道的其他常用骨替代物相似。牙槽骨切开术内部的新骨分数几乎是窦腔内部的两倍,而残留生物材料的量则远低于窦腔内部。